ISRCTN65030013进行中（未招募）未知
Therapy Personalisation using Multiomic Analyses in Inflammatory Bowel Disease – THAMES-IBD
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 入组人数
- 468
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Healthy control patients:
- •1.1. =18 years-old
- •1.2. Willing to consent to sample collection
- •1.3. No prior diagnosis or current clinical suspicion of IBD
- •2. Inflammatory bowel disease patients, including ulcerative colitis, Crohn’s disease and IBD-unclassified
- •2.1. Active disease as determined by standard clinical parameters measured within the 2 months prior to recruitment:
- •- Crohn's symptom flare as indicated by Harvey-Bradshaw score >5 or unweighted PRO-2 (CD) of average daily stool stool frequency (SF) score =4 and/or average daily abdominal pain (AP) score =2,
- •- faecal calprotectin =250micrograms/gram;
- •- UC / IBD-U symptom flare as indicated by PRO-2 (UC) of =3 including a rectal bleeding score of =1,
- •- faecal calprotectin =250micrograms/gram.
- •3. Able to consent to the study (with interpreter, if required)
排除标准
- •Unable or unwilling to provide informed consent
研究者
相似试验
已完成
不适用
Study for personalized medicine based on pharmacokinetics and pharmacodynamics concerned with therapeutic drug of nontuberculous mycobacterium.JPRN-UMIN000020406Center for Infectious Disease and Infection Control10
招募中
Unknown
Deep-phenotyping and personalized therapy of patients with irritable bowel syndromeF45.32K58Irritable bowel syndromeDRKS00032767niversitätsklinikum Heidelberg, Abteilung für Allgemeine Innere Medizin und Psychosomatik75
招募中
4 期
Treatment of neovascular AMD: Artificial intelligence in real-world setting2024-518482-99-01Medical University Of Vienna290
已完成
不适用
Biomarker testing for Personalized Therapy in real world setting; First line treatment decision in the advanced non-squamous NSCLCnon-squamous Non-small-cell lung carcinomaJPRN-UMIN000030618AstraZeneca K.K.200
招募中
不适用
Genetic Biomarker Research for Personalized Therapy of Chorioretinal Neovascular DiseasesDiseases of the eye and adnexaKCT0001055Inje University Busan Paik Hospital1,000